Skip to content

The effect of self-selected open-label placebos on pain perception in women

The effect of self-selected open-label placebos on pain perception in women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038359
Enrollment
90
Registered
2025-11-21
Start date
2025-12-12
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy sample

Interventions

Group 1: Self-selected open-label placebo: After the subject has completed the pain paradigm for the first time, she is presented with a selection of eight different placebos. The subject can choose

Sponsors

Universität Graz
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Healthy women between the ages of 18 and 35

Exclusion criteria

Exclusion criteria: Cardiovascular disease, epilepsy, neurodermatitis, chronic pain disorder, metallic implants near the heart or pacemakers, severe psychiatric illness (e.g., schizophrenia), pregnancy

Design outcomes

Primary

MeasureTime frame
Immediately after each electrocutaneous stimulus is administered, the perceived intensity of the stimulus is queried (on a scale from 0 = not intense at all to 100 = very intense).

Secondary

MeasureTime frame
The following questionnaires are provided in an online survey prior to on-site testing: Brief Short Inventory (BSI; Spitzer et al., 2011) Pain Sensitivity Questionnaire (PSQ; Ruscheweyh et al., 2009) Positive Superstition (based on Carlson, Mowen & Fang, 2009)

Countries

Austria

Contacts

Public ContactAnne Schienle

Universität Graz

anne.schienle@uni-graz.at+43 316 380 5086

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026